HomeChoice Partners, Inc. dba Bioscrip Infusion Services – FDA Inspection, Sep 19, 2018

Record Details

This FDA Inspection record concerns HomeChoice Partners, Inc. dba Bioscrip Infusion Services, with an inspection on September 19, 2018, issued by the Kansas City District Office, covering human drugs.

Company: HomeChoice Partners, Inc. dba Bioscrip Infusion Services
Inspection Date: September 19, 2018
Product Type: Human Drugs
Office: Kansas City District Office
Person: Tiara N Brown-Crosen (Issuing Officer)

View Company Profile

ID · a348ff16-898e-413d-990b-5adf5ceaead1

Inspection Facts

Inspection number: 1066631
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

FDA Citations

FDCA 501(a)(2)(A)Beta-lactam drugs, inadequate sanitation
FDCA 501(a)(2)(A)Personnel contact outside ISO 5 area

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore HomeChoice Partners, Inc. dba Bioscrip Infusion Services

FDA Inspection

HomeChoice Partners, Inc. dba Bioscrip Infusion ServicesSeptember 19, 2018